|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020792,
umls-concept:C0030705,
umls-concept:C0034819,
umls-concept:C0085295,
umls-concept:C0162643,
umls-concept:C0229671,
umls-concept:C0332167,
umls-concept:C1332225,
umls-concept:C1511790,
umls-concept:C1515021,
umls-concept:C1749467
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1994-10-13
|
|
pubmed:abstractText |
This study explores the ability of the combined detection of soluble IL-2 receptor (sIL-2r) and interleukin-10 (IL-10) to predict treatment failure in patients with aggressive non-Hodgkin's lymphoma (NHL) and to evaluate the modifications in cytokine measurements induced by the therapeutic administration of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1792-800
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8082082-Adolescent,
pubmed-meshheading:8082082-Adult,
pubmed-meshheading:8082082-Female,
pubmed-meshheading:8082082-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:8082082-Humans,
pubmed-meshheading:8082082-Interleukin-10,
pubmed-meshheading:8082082-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8082082-Male,
pubmed-meshheading:8082082-Middle Aged,
pubmed-meshheading:8082082-Neoplasm Staging,
pubmed-meshheading:8082082-Prognosis,
pubmed-meshheading:8082082-Receptors, Interleukin-2,
pubmed-meshheading:8082082-Recurrence,
pubmed-meshheading:8082082-Remission Induction
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
|
|
pubmed:affiliation |
Department of Hematology, University of Rome Tor Vergata, Italy.
|
|
pubmed:publicationType |
Journal Article
|
